Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,467.99
-15.5126-1.05%
Number of Gainers:4
Number of Losers:3
Number of Flat:- -
PE:- -
High:1,484.35
Open:1,484.35
Low:1,448.98
Close:1,483.50
Volume:89.92M
Turnover:6.66B
Market Cap:1.53T
Float Cap:1.48T

Loading ...

How JNJ, TEM, and LLY Used AI to Redefine Healthcare Compounding

TIPRANKS
·
2 hours ago

Arvinas FY 2025 net loss narrows to USD 80.8 million (59.4%)

Reuters
·
5 hours ago

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
5 hours ago

Pfizer initiated with an Underperform at RBC Capital

TIPRANKS
·
6 hours ago

Amgen to Present at TD Cowen Health Care Conference

Reuters
·
6 hours ago

Pfizer Gets Full FDA Approval for Braftovi Combination for Colon Cancer Treatment

MT Newswires Live
·
6 hours ago

U.S. FDA Grants Full Approval to Pfizer’s Braftovi Combination Regimen in First-Line Metastatic Colorectal Cancer

THOMSON REUTERS
·
7 hours ago

BRIEF-FDA Grants Traditional Approval To Encorafenib For Metastatic Colorectal Cancer With Braf V600e Mutation

Reuters
·
8 hours ago

FDA: Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a Braf V600e Mutation

THOMSON REUTERS
·
9 hours ago

Novo Nordisk price target lowered to DKK 270 from DKK 340 at Barclays

TIPRANKS
·
10 hours ago

Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market

Dow Jones
·
10 hours ago

Eli Lilly's Breast Cancer Drug Inluriyo Approved by UK Regulator

MT Newswires Live
·
10 hours ago

BRIEF-UK's MHRA Approves Imlunestrant Tosylate (Inluriyo) For Treatment Of Breast Cancer

Reuters
·
10 hours ago

UK's Mhra - Approved Imlunestrant Tosylate (Inluriyo) for Treatment for Breast Cancer

THOMSON REUTERS
·
10 hours ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

MT Newswires Live
·
11 hours ago

BofA sees limited impact to Eli Lilly’s franchise from Novo’s GLP-1 price update

TIPRANKS
·
Yesterday

Eli Lilly Introduces Monthly Zepbound Injection Pen

Deep News
·
Yesterday

Eli Lilly Shares Down 1.2% After Report Novo Nordisk to Cut US List Prices for Ozempic, Wegovy by up to 50%

THOMSON REUTERS
·
Yesterday

Eli Lilly Shares Dip Over 1.5% in Premarket Trading Following Rival Novo Nordisk's GLP-1 Drug Price Reduction Announcement

Stock News
·
Yesterday

Novo Nordisk Stock (NVO) Sinks Further on Wegovy and Ozempic Price-Cut Plan

TIPRANKS
·
Yesterday